Inhibikase Therapeutics, Inc. - Common Stock (IKT)

1.6350
-0.0250 (-1.51%)
NASDAQ· Last Trade: Jun 5th, 12:34 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors